GN
Gary Nachman Raymond James Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
AbbVie
ABBV
$375B
| $212.56 | $236 |
11%
upside
| Outperform | 1 month ago |
|
|
LENZ
2
LENZ Therapeutics
LENZ
$1.2B
| $41.98 | $40 |
5%
downside
| Outperform | 1 month ago |
|
3
Ionis Pharmaceuticals
IONS
$9.76B
| $61.23 | $64 |
5%
upside
| Strong Buy | 1 month ago |
|
4
Schrodinger
SDGR
$1.41B
| $19.13 | $28 |
46%
upside
| Outperform | 9 months ago |
|
5
Alnylam Pharmaceuticals
ALNY
$59.2B
| $452 | $298 |
34%
downside
| Outperform | 10 months ago |
|
6
Pacira BioSciences
PCRX
$1.19B
| $26.45 | $37 |
40%
upside
| Outperform | 1 year ago |
|
7
Bausch + Lomb
BLCO
$5.31B
| $15.01 | $19 |
27%
upside
| Outperform | 1 year ago |
|
8
Scholar Rock
SRRK
$3.02B
| $31.41 | $30 |
4%
downside
| Strong Buy | 1 year ago |
|
9
Aquestive Therapeutics
AQST
$656M
| $5.42 | $7 |
29%
upside
| Outperform | 1 year ago |
|
10
Amneal Pharmaceuticals
AMRX
$3.02B
| $9.62 | $4 |
58%
downside
| Market Perform | 2 years ago |
|
11
Phathom Pharmaceuticals
PHAT
$875M
| $12.34 | $30 |
143%
upside
| Outperform | 2 years ago |
|
|
12
Ionis Pharmaceuticals
IONS
$9.76B
| $61.23 | $67 |
9%
upside
| Outperform | 2 years ago |
|
13
AbCellera Biologics
ABCL
$1.26B
| $4.22 | $32 |
658%
upside
| Outperform | 2 years ago |
|
14
Viatris
VTRS
$12.2B
| $10.50 | $14 |
33%
upside
| Market Perform | 2 years ago |
|
|
15
AbbVie
ABBV
$375B
| $212.56 | $167 |
21%
downside
| Outperform | 2 years ago |
|
|
16
Pacira BioSciences
PCRX
$1.19B
| $26.45 | $52 |
97%
upside
| Market Perform | 2 years ago |
|
|
17
Scholar Rock
SRRK
$3.02B
| $31.41 | $32 |
2%
upside
| Outperform | 2 years ago |
|
18
Teva Pharmaceuticals
TEVA
$21.7B
| $18.95 | $10 |
47%
downside
| Market Perform | 2 years ago |
|
19
Rigel Pharmaceuticals
RIGL
$742M
| $41.34 | $30 |
27%
downside
| Outperform | 2 years ago |
|
|
20
Alnylam Pharmaceuticals
ALNY
$59.2B
| $452 | $200 |
56%
downside
| Market Perform | 3 years ago |
|
21
Bausch Health
BHC
$2.72B
| $7.35 | $8 |
9%
upside
| Market Perform | 3 years ago |
|
22
Jazz Pharmaceuticals
JAZZ
$7.86B
| $129.50 | $188 |
45%
upside
| Outperform | 3 years ago |
|
23
Amphastar Pharmaceuticals
AMPH
$1.37B
| $29.42 | $21 |
29%
downside
| Market Perform | 5 years ago |
|